CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD

Highlights Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
22.32 ^CNY	-2.45%		-2.28%	+21.04%

04-29	Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug	MT
04-29	Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 May 2024	05-21	CI
Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug	04-29	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023	04-24	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Kanghong Pharmaceutical's Mosapride Citrate Tablets Wins Centralized Procurement Bid	04-17	MT
Kanghong Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug	02-27	MT
Kanghong Pharmaceutical Gets Nod for Registration of Escitalopram Oxalate Tablets	12-12	MT
Kanghong Pharma's Aripiprazole Oral Solution Chosen for China's Centralized Drug Procurement	11-08	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Kanghong Pharma Gets Nod to Trial Antidepressant	23-07-20	MT
Kanghong Pharma Gets Continued Protection for Traditional Chinese Medicine	23-06-20	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 6, 2023	23-05-30	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022	23-05-24	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Kanghong Pharma Sees 121% Jump in 2022 Profit	23-01-19	MT
Kanghong Pharma Gets Marketing Nod in China for Antidepressant	22-12-23	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

Highlights

Filters